Darshan Doshi, MD, MS

Interventional Cardiologist
Massachusetts General Hospital / Harvard Medical School, Massachusetts, United States

Dr. Darshan Doshi is an interventional cardiologist who directs the complex coronary artery disease program at the Massachusetts General Hospital/Harvard Medical School. He specializes in chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent instent restenosis. He also has a special interest in the use of intravascular imaging and physiology to improve outcomes.

Presentation(s):

• Live Case from Medstar Washington Hospital Center | Washington, DC

  Sunday, February 26, 2023
  8:00 AM – 8:45 AM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Is Imaging Mandatory for Left Main PCI?

  Sunday, February 26, 2023
  10:08 AM – 10:16 AM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Panel Discussion

  Sunday, February 26, 2023
  10:56 AM – 11:15 AM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Managing Nodular Calcium with Atherectomy + IVL

  Sunday, February 26, 2023
  1:04 PM – 1:12 PM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Panel Discussion

  Sunday, February 26, 2023
  1:20 PM – 1:30 PM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Case Presentation #2 | My Strategy for Diffuse Lesions

  Monday, February 27, 2023
  5:15 PM – 5:30 PM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Group Discussion | Modern PCI for Calcified Lesions

  Monday, February 27, 2023
  5:45 PM – 6:00 PM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)

• Effect of Baseline TIMI Thrombus Grade on Safety and Performance Outcomes in High Thrombus Burden Acute Coronary Syndrome Patients Treated with Sustained Mechanical Aspiration Thrombectomy Before Percutaneous Coronary Intervention: A Subset Analysis of the CHEETAH Study

  Monday, February 27, 2023
  11:00 AM – 11:08 AM ET

  Disclosure(s): Abbott Vascular: Speakers' Bureau (Ongoing); Acist Medical: Consultant/Advisory Board (Ongoing); Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consultant/Advisory Board (Ongoing); Cordis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CrossLiner, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); Penumbra, Inc.: Consultant/Advisory Board (Ongoing); Philips-Volcano: Consultant/Advisory Board (Ongoing); Shockwave Medical: Consultant/Advisory Board (Ongoing); Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)